Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 was added to the history, replacing the prior v3.6.5. This reflects a minor platform update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new platform revision entry (v3.6.5) has been added to the record history, replacing the previous v3.6.4. This indicates a software/UI update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:56:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page history shows the latest site revision as v3.6.4, replacing the previous v3.6.3, indicating a platform update.
    Difference
    0.1%
    Check dated 2026-07-25T12:46:47.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small platform update rather than a change to the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:15.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a minor platform update to the history-tracking interface rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The record history now shows that participant recruitment has ended and the study documentation has a new revision (v3.6.0), with the prior revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:18.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.